BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31305163)

  • 1. Association of galectin-3 with changes in left ventricular function in recent-onset dilated cardiomyopathy.
    Rieth AJ; Jung C; Gall H; Rolf A; Mitrovic V; Hamm CW; Sperzel J; Liebetrau C
    Biomarkers; 2019 Nov; 24(7):652-658. PubMed ID: 31305163
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
    Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of timely measurement of galectin-3, NT-proBNP, cystatin C and hsTnT in predicting prognosis and heart function after heart transplantation.
    Franeková J; Hošková L; Sečník P; Pazderník M; Kotrbatá M; Kubíček Z; Jabor A
    Clin Chem Lab Med; 2016 Feb; 54(2):339-44. PubMed ID: 26351922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.
    Wojciechowska C; Romuk E; Nowalany-Kozielska E; Jacheć W
    Hellenic J Cardiol; 2017; 58(5):350-359. PubMed ID: 28363768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
    Kim G; Lee OJ; Kang IS; Song J; Huh J
    Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure.
    Huang Y; Lin Y; Zhang S; Wang Z; Zhang J; Chang C; Liu L; Ji Q; Liu X
    Dis Markers; 2016; 2016():6762825. PubMed ID: 27313334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of plasma galectin-3 in patients with chronic heart failure.
    Chen K; Jiang RJ; Wang CQ; Yin ZF; Fan YQ; Cao JT; Han ZH; Wang Y; Song DQ
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1005-11. PubMed ID: 23661512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
    Nasser N; Perles Z; Rein AJJT; Nir A
    Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy.
    Vergaro G; Del Franco A; Giannoni A; Prontera C; Ripoli A; Barison A; Masci PG; Aquaro GD; Cohen Solal A; Padeletti L; Passino C; Emdin M
    Int J Cardiol; 2015 Apr; 184():96-100. PubMed ID: 25697876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of trimetazidine combined with perindopril on NT-proBNP level in rats with dilated cardiomyopathy.
    Lin J; Zhong B; Yan J; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):198-203. PubMed ID: 32415948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.
    Luchner A; Hengstenberg C; Löwel H; Buchner S; Schunkert H; Riegger GA; Holmer S
    J Card Fail; 2005 Jun; 11(5 Suppl):S21-7. PubMed ID: 15948096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy.
    Stämpfli SF; Erhart L; Hagenbuch N; Stähli BE; Gruner C; Greutmann M; Niemann M; Kaufmann BA; Jenni R; Held L; Tanner FC
    Int J Cardiol; 2017 Jun; 236():321-327. PubMed ID: 28268080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy.
    Codognotto M; Piccoli A; Zaninotto M; Mion M; Vertolli U; Tona F; Boffa GM
    Am J Nephrol; 2007; 27(1):1-6. PubMed ID: 17204831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.